Document is current
Any future updates will be listed below
-
Authors
Bassatne, Aya https://orcid.org/0000-0002-7841-3986
Rizo, Ivania https://orcid.org/0000-0002-3933-9461
- License Information
-
More Information
Article History
Received: 17 December 2025
Accepted: 17 March 2026
First Online: 9 April 2026
Declarations
:
: Ivania Rizo reports advisory fees from Novo Nordisk and Genentech. Aya Bassatne declares no competing interest.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
